Showing results (21-30 of 40) with videos related to
Sort By:
Pageof 4
Current Medical Research and Opinion|January 6, 2017
Targeting the PD-1 pathway: a new hope for gastrointestinal cancersBurak Bilgin, Mehmet A N Sendur, Muhammed Bülent Akıncı, et al.European Radiology|July 27, 2001
Power Doppler ultrasonography for the evaluation of skin tumors other than malignant melanomaG C Karaman, C Z Karaman, N Sendur, et al.Current Medical Research and Opinion|September 16, 2014
The efficacy of adjuvant trastuzumab in HER-2 positive breast cancer with axillary lymph node metastases according to the treatment durationMehmet A N Sendur, Sercan Aksoy, Nuriye Y Ozdemir, et al.Current Medical Research and Opinion|January 17, 2020
A historical turning point for the treatment of advanced renal cell carcinoma: inhibition of immune checkpointMutlu Hizal, Mehmet A N Sendur, Burak Bilgin, et al.Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology|April 11, 2016
Effect of body mass index on the efficacy of adjuvant tamoxifen in premenopausal patients with hormone receptor-positive breast cancerMehmet A N Sendur, Sercan Aksoy, Nuriye Y Ozdemir, et al.Current Medical Research and Opinion|February 14, 2013
Trastuzumab emtansine (T-DM1) for HER2-positive breast cancerBaris Boyraz, Mehmet A N Sendur, Sercan Aksoy, et al.Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology|September 26, 2013
Variations in tumor marker levels in metastatic breast cancer patients according to tumor subtypesT Kos, S Aksoy, M A N Sendur, et al.Renal Failure|March 28, 2013
Evaluation of the renal function using cystatin C level in the patients receiving cisplatin-based chemotherapyF T Kos, M A N Sendur, S Aksoy, et al.Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology|March 25, 2014
Evaluation of erectile dysfunction risk factors in young male survivors of colorectal cancerMehmet A N Sendur, Sercan Aksoy, Nuriye Y Ozdemir, et al.Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology|April 25, 2013
Administration of contrast media just before cisplatin-based chemotherapy increases cisplatin-induced nephrotoxicityM A N Sendur, S Aksoy, S Yaman, et al.Pageof 4